Cargando…

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”

Detalles Bibliográficos
Autores principales:	Busetto, Gian Maria, Falagario, Ugo Giovanni, Carrieri, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Invited Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521946/ https://www.ncbi.nlm.nih.gov/pubmed/36629159 http://dx.doi.org/10.4103/aja2022114

Ejemplares similares

Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy
por: Porcaro, Antonio Benito, et al.
Publicado: (2023)

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Endogenous testosterone and mortality risk
por: Meyer, Emily J, et al.
Publicado: (2018)

Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy
por: Porcaro, Antonio Benito, et al.
Publicado: (2023)

Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer
por: Porcaro, Antonio Benito, et al.
Publicado: (2021)

Retzius-sparing robotic radical prostatectomy
por: Eden, Christopher G
Publicado: (2019)

Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives
por: Canda, Abdullah Erdem, et al.
Publicado: (2015)

Commentary on “Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy”
por: Yap, Tet
Publicado: (2021)

Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques
por: d’Altilia, Nicola, et al.
Publicado: (2022)

Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer
por: Porcaro, Antonio Benito, et al.
Publicado: (2021)

Radical prostatectomy in patients aged 75 years or older: review of the literature
por: Mandel, Philipp, et al.
Publicado: (2019)

Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer
por: Falagario, Ugo Giovanni, et al.
Publicado: (2021)

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
por: Gao, Yuan, et al.
Publicado: (2016)

Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy
por: Alyamani, Mohammad, et al.
Publicado: (2023)

Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio Benito, et al.
Publicado: (2022)

Male esthetic genital surgery: recommendations and gaps to be filled
por: Bettocchi, Carlo, et al.
Publicado: (2022)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Funneling of the bladder neck - radiological appearance after radical retropubic prostatectomy and clinical relevance
por: Bugeja, Simon, et al.
Publicado: (2019)

Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy
por: Sciarra, Alessandro, et al.
Publicado: (2021)

Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation
por: Selvaggio, Oscar, et al.
Publicado: (2023)

Low endogenous testosterone levels are associated with the extend of lymphnodal invasion at radical prostatectomy and extended pelvic lymph node dissection
por: Porcaro, Antonio Benito, et al.
Publicado: (2021)

Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
por: Ferro, Matteo, et al.
Publicado: (2020)

Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis
por: Zapała, Piotr, et al.
Publicado: (2023)

Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
por: Morgentaler, Abraham, et al.
Publicado: (2015)

Orgasm-associated urinary incontinence (climacturia) following radical prostatectomy: a review of pathophysiology and current treatment options
por: Kannady, Christopher, et al.
Publicado: (2020)

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
por: Lee, Hye Won, et al.
Publicado: (2015)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy
por: Martini, Alberto, et al.
Publicado: (2020)

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019)

One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2022)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

Comparing the Oncological Outcomes of Cryoablation vs. Radical Prostatectomy in Low-Intermediate Risk Localized Prostate Cancer
por: Guo, Xiao-xiao, et al.
Publicado: (2020)

Performance characteristics of prostate-specific antigen density and biopsy primary Gleason score to predict biochemical failure in patients with intermediate prostate cancer who underwent radical prostatectomy
por: Peng, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_216j0mdif5t9ftcgru56i90akr